A detailed history of Schroder Investment Management Group transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Schroder Investment Management Group holds 50,555 shares of JAZZ stock, worth $6.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,555
Previous 31,143 62.33%
Holding current value
$6.32 Million
Previous $3.32 Million 69.55%
% of portfolio
0.01%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.57 - $116.37 $1.95 Million - $2.26 Million
19,412 Added 62.33%
50,555 $5.63 Million
Q2 2024

Aug 12, 2024

SELL
$103.94 - $118.98 $2.82 Million - $3.23 Million
-27,114 Reduced 46.54%
31,143 $3.32 Million
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $1.23 Million - $1.42 Million
10,698 Added 22.49%
58,257 $7.02 Million
Q4 2023

Feb 13, 2024

BUY
$114.26 - $136.0 $4.92 Million - $5.85 Million
43,044 Added 953.36%
47,559 $5.85 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $462,624 - $551,015
-3,792 Reduced 45.65%
4,515 $584,000
Q2 2023

Aug 11, 2023

SELL
$122.5 - $147.16 $14.2 Million - $17.1 Million
-116,318 Reduced 93.33%
8,307 $1.03 Million
Q1 2023

May 11, 2023

SELL
$133.98 - $160.47 $3.35 Million - $4.01 Million
-24,995 Reduced 16.71%
124,625 $18.2 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $1.76 Million - $2.17 Million
13,596 Added 10.0%
149,620 $23.8 Million
Q3 2022

Nov 10, 2022

SELL
$126.59 - $161.18 $790,174 - $1.01 Million
-6,242 Reduced 4.39%
136,024 $18.1 Million
Q2 2022

Aug 11, 2022

SELL
$141.59 - $168.66 $6.08 Million - $7.24 Million
-42,941 Reduced 23.19%
142,266 $22.2 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $5.05 Million - $6.25 Million
38,921 Added 26.61%
185,207 $29.2 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $2.65 Million - $3.22 Million
-22,105 Reduced 13.13%
146,286 $18.6 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $4.34 Million - $6.24 Million
33,752 Added 25.07%
168,391 $21.9 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $3.77 Million - $4.39 Million
23,557 Added 21.21%
134,639 $23.9 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $3.19 Million - $3.68 Million
21,223 Added 23.62%
111,082 $18.3 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $2.09 Million - $2.45 Million
-14,850 Reduced 14.18%
89,859 $14.8 Million
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $2.77 Million - $3.79 Million
-26,289 Reduced 20.07%
104,709 $15 Million
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $195,856 - $249,488
2,047 Added 1.59%
130,998 $14.5 Million
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $5.4 Million - $9.4 Million
-61,548 Reduced 32.31%
128,951 $13.6 Million
Q4 2019

Feb 11, 2020

BUY
$117.65 - $153.73 $2.84 Million - $3.71 Million
24,131 Added 14.5%
190,499 $28.4 Million
Q3 2019

Nov 12, 2019

BUY
$125.18 - $143.24 $3.56 Million - $4.08 Million
28,468 Added 20.64%
166,368 $21.2 Million
Q2 2019

Aug 08, 2019

BUY
$125.55 - $144.48 $13.8 Million - $15.9 Million
110,047 Added 395.1%
137,900 $19.7 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $86,955 - $125,055
-750 Reduced 2.62%
27,853 $3.45 Million
Q3 2018

Nov 13, 2018

SELL
$161.01 - $180.57 $18.7 Million - $20.9 Million
-115,950 Reduced 80.21%
28,603 $4.81 Million
Q2 2018

Aug 13, 2018

SELL
$146.33 - $183.18 $11.2 Million - $14.1 Million
-76,747 Reduced 34.68%
144,553 $25.1 Million
Q1 2018

May 11, 2018

SELL
$135.59 - $157.16 $4.42 Million - $5.12 Million
-32,600 Reduced 12.84%
221,300 $33.4 Million
Q4 2017

Feb 09, 2018

SELL
$131.06 - $150.39 $13.2 Million - $15.2 Million
-101,000 Reduced 28.46%
253,900 $34.2 Million
Q3 2017

Nov 09, 2017

BUY
$142.62 - $155.6 $50.6 Million - $55.2 Million
354,900
354,900 $52.6 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.84B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.